Conclusion
This study reports demographic features of the consecutive 47 patients treated at a new proton therapy centre in the initial 14 months. This study also showed that PBT can bedelivered safely with acceptable acute toxicitiesfor judiciously selected children and young adults with CNS and non-CNS tumors. A longer follow-up is needed to evaluate its efficacy with respect to disease outcomes and late toxicities.
Conflicts of interest: No